Typicality: | 0.614 |
Saliency: | 0.473 |
in 2006 | 14 | temporal |
for use by the public | 11 | purpose |
in june | 9 | temporal |
vaccine → be approved by → the fda | 56 |
vaccine → be approved by → the food and drug administration | 33 |
vaccine → be approved by → fda | 8 |
negative | neutral | positive |
0.100 | 0.607 | 0.292 |
Raw frequency | 97 |
Normalized frequency | 0.473 |
Modifier score | 1.000 |
Perplexity | 28.875 |